Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T18:04:57.951Z.
Calculation as of: 2026-10-06T18:04:57.951Z.
Quote observation: 2026-10-06T18:00:24.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 54b27289092361ea6502e61cba635145b9acb525321868e00b72fceafc9e89d3
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Market Cap
$1.72B
EV/FCF Ratio
26.52x
TTM Avg
43.76x
3Y Avg
32.49x
5Y Avg
29.03x
Market Cap
$1.73B
EV/FCF Ratio
N/A
TTM Avg
6.04x
3Y Avg
6.04x
5Y Avg
6.04x
Market Cap
$1.74B
EV/FCF Ratio
N/A
TTM Avg
126.26x
3Y Avg
66.65x
5Y Avg
66.65x
Market Cap
$1.75B
EV/FCF Ratio
34.64x
TTM Avg
62.48x
3Y Avg
62.48x
5Y Avg
62.48x
Market Cap
$1.75B
EV/FCF Ratio
29.61x
TTM Avg
29.39x
3Y Avg
35.76x
5Y Avg
82.00x
Market Cap
$1.64B
EV/FCF Ratio
510.59x
TTM Avg
489.34x
3Y Avg
489.34x
5Y Avg
489.34x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Personalis, Inc. (PSNL) | $1.70B | N/A | N/A | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.72B | 26.52x | 43.76x | 32.49x | 29.03x |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.73B | N/A | 6.04x | 6.04x | 6.04x |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.74B | N/A | 126.26x | 66.65x | 66.65x |
| Xeris Biopharma Holdings, Inc. (XERS)vs › | $1.75B | 34.64x | 62.48x | 62.48x | 62.48x |
| Surgery Partners, Inc. (SGRY)vs › | $1.75B | 29.61x | 29.39x | 35.76x | 82.00x |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.64B | 510.59x | 489.34x | 489.34x | 489.34x |
| Novocure Ltd (NVCR)vs › | $1.77B | N/A | 434.55x | 309.38x | 391.85x |
| Absci Corporation (ABSI)vs › | $1.78B | N/A | N/A | N/A | N/A |
| Generate Biomedicines, Inc. (GENB)vs › | $1.78B | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
